Dupont Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-8,360
Closed -$815K 658
2015
Q1
$815K Hold
8,360
0.02% 470
2014
Q4
$776K Hold
8,360
0.01% 506
2014
Q3
$575K Sell
8,360
-8,600
-51% -$592K 0.01% 543
2014
Q2
$1.78M Buy
+16,960
New +$1.78M 0.03% 397